🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Status
Completed
Location
Southampton University Hospitals NHS Tust
Start Date
2017-06-02
Trial ID
NCT03571308
Treatments Being Tested
The primary objective of this study is to evaluate the safety of zanubrutin...
Status
Completed
Location
Rocky Mountain Cancer Centers (Williams) Usor
Start Date
2019-10-15
Trial ID
NCT04116437
Treatments Being Tested
This study will be a 2-part, open-label, single-center relative bioavailabi...
Status
Completed
Location
Research Site
Start Date
2020-06-24
Trial ID
NCT04488016
Within this exploratory multicohort phase II trial, SAKK aims to evaluate a...
Status
Active Not Recruiting
Location
Ospedale Papa Giovanni XXIII
Start Date
2021-06-25
Trial ID
NCT04604067
Treatments Being Tested
This study is to determine the response to acalabrutinib in patients with c...
Status
Completed
Location
Research Site
Start Date
2015-01-12
Trial ID
NCT02337829
Treatments Being Tested
This phase II trial compares three chemotherapy regimens consisting of bend...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2019-12-13
Trial ID
NCT04115631
Treatments Being Tested
This is a study for participants with a type of blood cancer called mantle ...
Status
Active Not Recruiting
Location
Alaska Oncology and Hematology, LLC
Start Date
2021-04-08
Trial ID
NCT04662255
Treatments Being Tested
This trial will study how safely the tazemetostat works with other therapie...
Status
Withdrawn
Location
California Cancer Associates For Research And Excellence, cCARE
Start Date
2021-12-22
Trial ID
NCT05205252
To evaluate the tolerability,feasibility, and efficacy of combining acalabr...
Status
Unknown
Location
Swedish Cancer Institute
Start Date
2019-08-16
Trial ID
NCT03736616
This study aims to evaluate the safety, tolerability, pharmacodynamic, and ...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital ( Site 0140)
Start Date
2017-06-26
Trial ID
NCT03162536
Treatments Being Tested